Lupin on Wednesday said it has received approval from the USFDA for Formoterol Fumarate Inhalation Solution, used in treating symptoms of chronic obstructive pulmonary disease.
The company has received approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of Mylan Specialty’s Perforomist Inhalation Solution, the Mumbai-based drug maker said in a statement.
As per IQVIA MAT June 2022 data, the medication had annual sales of around USD 282 million in the US market.
Shares of Lupin ended 2.55 per cent down at Rs 677.65 apiece on the BSE on Wednesday.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
The Amex Gold Card is often seen as a top 'lifestyle' credit card in 2026…
The Amex Platinum Card is changing some benefits this summer, including Uber perks, event access,…
Impact Wrestling fans can easily activate the Impact Plus app on Roku, FireStick, Smart TV,…
To activate MTV on Roku, Firestick, Smart TV, or Apple TV, install the app, get…
Learn how to activate Noggin on Roku, Fire Stick, Smart TV and Apple TV using…
Activating The Zeus Network on Roku, Firestick, Apple TV, Android TV, and Smart TVs is…